Structure Therapeutics Inc. (GPCR) Ownership

$27.50

south_east
-$0.26 (-0.94%)
Day's range
$27.05
Day's range
$28.39

Structure Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CAPITAL RESEARCH GLOBAL INVESTORS 02/13/2025 3.54 M $95.93 M   0.20% 2.24%
DEEP TRACK CAPITAL, LP 02/14/2025 2.80 M $75.94 M   129.41% 1.77%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 2.06 M $55.80 M   -18.56% 1.30%
BVF INC/IL 02/14/2025 1.77 M $48.04 M   -20.88% 1.12%
VESTAL POINT CAPITAL, LP 02/14/2025 1.73 M $46.78 M   50.00% 1.09%
CAPITAL INTERNATIONAL INVESTORS 02/13/2025 1.62 M $43.91 M   6.80% 1.03%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 1.52 M $41.15 M   -20.00% 0.96%
FIL LTD 02/13/2025 1.30 M $35.26 M   -0.80% 0.82%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 1.08 M $29.32 M   1.60% 0.68%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 1.06 M $28.83 M   0.00% 0.67%
FRANKLIN RESOURCES INC 02/12/2025 738,090 $20.02 M   4.53% 0.47%
CASDIN CAPITAL, LLC 02/14/2025 700,000 $18.98 M   0.00% 0.44%
LOGOS GLOBAL MANAGEMENT LP 02/14/2025 700,000 $18.98 M   -44.00% 0.44%
ORBIMED ADVISORS LLC 02/14/2025 652,028 $17.68 M   69.93% 0.41%
AMERICAN CENTURY COMPANIES INC 02/11/2025 612,616 $16.61 M   12.35% 0.39%
BLACKROCK FUNDING, INC. /DE 02/07/2025 610,585 $16.56 M   -10.22% 0.39%
MARSHALL WACE, LLP 02/13/2025 583,207 $15.82 M   339.57% 0.37%
02/14/2025 569,395 $15.44 M   100.00% 0.36%
02/14/2025 500,000 $13.56 M   100.00% 0.32%
BELLEVUE GROUP AG 02/14/2025 485,050 $13.15 M   -22.98% 0.31%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 476,698 $12.93 M   -61.50% 0.30%
FORESITE CAPITAL MANAGEMENT VI LLC 02/14/2025 420,000 $11.39 M   100.00% 0.27%
FIRST LIGHT ASSET MANAGEMENT, LLC 02/14/2025 398,855 $10.82 M   -21.21% 0.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/14/2025 373,407 $10.13 M   -55.78% 0.24%
BAKER BROS. ADVISORS LP 02/14/2025 361,565 $9.81 M   322.88% 0.23%
WOODLINE PARTNERS LP 02/14/2025 333,901 $9.06 M   0.70% 0.21%
ENSIGN PEAK ADVISORS, INC 02/14/2025 308,241 $8.36 M   67.72% 0.20%
CAMBER CAPITAL MANAGEMENT LP 02/14/2025 300,000 $8.14 M   100.00% 0.19%
IKARIAN CAPITAL, LLC 02/14/2025 284,085 $7.70 M   146.60% 0.18%
SC CHINA HOLDING LTD 02/14/2025 266,062 $7.54 M   0.00% 0.17%
ARROWMARK COLORADO HOLDINGS LLC 02/14/2025 232,909 $6.32 M   -3.39% 0.15%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 221,000 $5.99 M   29.24% 0.14%
SUPERSTRING CAPITAL MANAGEMENT LP 02/14/2025 216,811 $5.88 M   -4.51% 0.14%
CANDRIAM S.C.A. 02/07/2025 215,421 $5.84 M   59.57% 0.14%
READYSTATE ASSET MANAGEMENT LP 02/14/2025 209,342 $5.68 M   149.22% 0.13%
ABRDN PLC 01/24/2025 171,388 $4.65 M   -21.05% 0.11%
HANDELSBANKEN FONDER AB 02/03/2025 165,000 $4.48 M   100.00% 0.10%
SILVERARC CAPITAL MANAGEMENT, LLC 02/14/2025 152,395 $4.13 M   116.11% 0.10%
EXOME ASSET MANAGEMENT LLC 02/14/2025 151,965 $4.12 M   26.46% 0.10%
ORBIMED ADVISORS LLC 02/14/2025 150,000 $4.07 M   100.00% 0.10%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 150,000 $4.07 M   100.00% 0.10%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 150,000 $4.07 M   100.00% 0.10%
CCG WEALTH MANAGEMENT, LLC 01/24/2025 150,000 $4.07 M   100.00% 0.10%
PIER CAPITAL, LLC 02/11/2025 132,604 $3.60 M   -1.26% 0.08%
MONASHEE INVESTMENT MANAGEMENT LLC 02/14/2025 132,000 $3.58 M   -17.30% 0.08%
RTW INVESTMENTS, LP 02/14/2025 125,000 $3.39 M   0.00% 0.08%
02/28/2025 113,992 $3.09 M   100.00% 0.07%
TD ASSET MANAGEMENT INC 02/11/2025 88,882 $2.41 M   -53.41% 0.06%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 83,148 $2.25 M   147.00% 0.05%
WEXFORD CAPITAL LP 02/14/2025 81,872 $2.22 M   -16.65% 0.05%

Structure Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 137 institutional investors and hedge funds held shares of Structure Therapeutics Inc.. The most heavily invested institutionals were:

Capital Research Global Investors: 3.54 M

Deep Track Capital, LP: 2.8 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 2.06 M

BVF INC/IL: 1.77 M

Vestal Point Capital, LP: 1.73 M

Capital International Investors: 1.62 M

38.39% of Structure Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 31.39 M shares in the last 24 months. This purchase volume represents approximately $863.32 M in transactions.